Genetic polymorphisms and erythrocyte sodium-lithium countertransport in essential hypertension

Clinica Chimica Acta

Volumn 255, Issue 1, 1996, Pages 39-55

  Tournoy, Kurt G ^a   Delanghe, Joris R ^a   Duprez, Daniel A ^a   De Buyzere, Marc L ^a   Verbeeck, Ronald M ^b   Vergauwe, Donald A ^b   Leroux Roels, Geert G ^a   Clement, Denis L ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Genetics; Heptoglobin; Hypertension; Polymorphism; Sodium lithium counter transport

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HAPTOGLOBIN; HEMOGLOBIN; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE; ESSENTIAL HYPERTENSION; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; ION TRANSPORT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SMOKING;

EID: 0030588934     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06389-9     Document Type: Article

References (42)

1. [1] Williams R, Hunt S, Hasstedt S et al. Definition of genetic factors in hypertension: a search for major genes, polygenes and homogeneous subtypes. J Cardiovasc Pharmacol 1988;12(Suppl. 3):S7-S20.
2. [2] Williams R, Hunt S, Hasstedt S et al. Current knowledge regarding the genetics of human hypertension. J Hypertens 1989;7(Suppl. 6):S8-S13.
3. [3] Canessa M, Adragna N, Solomon H. Connolly T, Tosteson D. Increased sodium- lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980;302:772-776.
4. [4] Strazullo P, Cappucio F, Trevisan M. The relationship of erythrocyte sodium-lithium countertransport to blood pressure and metabolic abnormalities in a sample of untreated middle-aged male workers. J Hypertens 1993;11:815-822.
5. [5] Ibsen K, Jensen H, Wieth J, Funder J. Essential hypertension: sodium-lithium countertransport in erythrocytes from patients and from children having one hypertensive parent. Hypertension 1982;4:703-709.
6. [6] Brugnara C, Corrocher R, Foroni L, Steinmayr M, Bonfanti F, De Sandre G. Lithium-sodium countertransport in erythrocytes of normal and hypertensive subjects. Relationship with age and plasma renin activity. Hypertension 1983;5:529-534.
7. [7] Turner S, Michels V. Sodium-lithium countertransport and hypertension in Rochester, Minnesota. Hypertension 1991;18:183-190.
8. [8] Laurenzi M, Trevisan M. Sodium-lithium countertransport and blood pressure: The Gubbio population study. Hypertension 1989;13:408-415.
9. [9] Issaksson H, Danielsson M, Rosenhamer G, Konarski-Svensson J, Ostergren J. Characteristics of patients resistant to antihypertensive drug therapy. J Intern Med 1991;229:421-426.
10. [10] Kuida H. Genetics of hypertension: what we know and don't know. Clin Exp Hypertens [A] 1990;12:865-876.
11. [11] Weder A, Schork N, Julius S. Linkage of MN locus and erythrocyte lithium-sodium countertransport in Tecumseh, Michigan. Hypertension 1991;17:977-981.
12. [12] Delanghe J, Duprez D, De Buyzere M et al. MN Blood group, a genetic marker for essential hypertension in young adults. Eur Heart J 1995;16:1269-1276.
13. [13] Delanghe J, Duprez D, De Buyzere M et al. Haptoglobin polymorphism and complications in established essential arterial hypertension. J Hypertens 1993;11:861-867.
14. [14] Tiret L, Rigat B, Visvikis S et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin 1-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
15. [15] Kojima S, Inenaga T, Matsuoka H et al. The association between salt sensitivity of blood pressure and some polymorphic factors. J Hypertens 1994;12:797-801.
16. [16] The Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee. 1993 Guidelines for the management of mild hypertension. Memorandum from a World Health Organisation/International Society of Hypertension meeting. Hypertension 1993;22:392-403.
17. [17] Harris M, Hadden W, Knowler W, Bennet P. International criteria for the diagnosis of diabetes and impaired glucose tolerance. Diabetes Care 1985;8:562-567.
18. [18] Schiller N, Shah P, Crawford M et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography, Committee on Standards Subcommittee. J Am Soc Echocardiogr 1989;2:358-367.
19. [19] Canessa M, Tosteson D. Determination of the sodium-lithium countertransport system of human erythrocytes. In: Johnson FM, Johnson F, eds. Medical practice. Baltimore: University Park Press, 1978;978-982.
20. [20] Smithies O. Zone electrophoresis in starch gels: grouped variations in the serum proteins of normal human adults. Biochem J 1955;61:629-641.
21. [21] Mollison PL. The MNSs system. In: Mollison PL, ed. Blood transfusion in clinical medicine, 6th edn. Oxford: Blackwell Scientific Publications, 1979;359-368.
22. [22] Lopes-Virella M, Stone P, Ellis S, Colwell J. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 1977;23:882-884.
23. [23] Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-509.
24. [24] Gleiberman L, Gershowitz H, Harburg E, Schork M. Blood pressure and blood group markers: association with the MN locus. J Hypertens 1984;2:337-341.
25. [25] Rutherford P, Thomas T, Wilkinson R. Increased erythrocyte sodium-lithium countertransport activity in essential hypertension is due to an increased affinity for extracellular sodium. Clin Sci 1990;79:365-369.
26. [26] Weder A, Schork N. Mixture analysis of erythrocyte sodium-Lithium countertransport and blood pressure. Hypertension 1989;13:145-150.
27. [27] Williams R, Hasstedt S, Hunt S et al. Genetic traits related to hypertension and electrolyte metabolism. Hypertension 1991;17(Suppl. 1):S169-S173.
28. [28] Turner S, Weidman W, Michels V et al. Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age. Hypertension 1989;13:378-391.
29. [29] Köhler W, Prokop O. Relationship between haptoglobin and Streptococcus pyogenes T4 antigens. Nature 1978;271:373.
30. [30] Jue D, Shim B, Kang Y. Inhibition of prostaglandin synthetase activity of sheep seminal vesicular gland by human serum haptoglobin. Mol Cell Biochem 1983;51:141-147.
31. [31] Weinberger M, Miller J, Fineberg N, Luft F, Grim C, Christian J. Association of haptoglobin with sodium sensitivity and resistance of blood pressure. Hypertension 1987;10:443-446.
32. [32] Luft F, Miller J, Grim C, Fineberg N, Christian J, Daugherty S. Salt sensitivity and resistance to blood pressure. Age and race as factors in physiological responses. Hypertension 1991;17(Suppl. 1):S1102-S1108.
33. [33] Bowman B, Yang E. DNA sequencing and chromosomal locations of human plasma protein genes. In: Putnam F, ed. The plasma proteins, 2nd edn. Orlando: Academic Press, 1987;5:1-48.
34. [34] Chapelle JP, Albert A, Smeets J, Heusghem C, Kulbertus H. Effects of the haptoglobin phenotype on the size of a myocardial infarct. N Engl J Med 1982;307:457-463.
35. + countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after antihypertensive treatment. Klin Wochenschr 1986;64:1101-1105.
36. [36] Carr S, Thomas T, Laker M, Wilkinson R. Elevated sodium-lithium countertransport: a familial marker of hyperlipidemia and hypertension. J Hypertens 1990;8:139-146.
37. [37] Hardman T, Dubrey S, Barlow R. Lack of acute effects of a standardised fat meal or exercise on erythrocyte sodium-lithium countertransport activity. J Hum Hypertens 1994;8:641-643.
38. [38] Lijnen P, Celis H, Fagard R, Staessen J, Amery A. Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems. J Hypertens 1994;12:59-64.
39. [39] Lijnen P, Feynvesi A. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men. Methods Find Exp Clin Pharmacol 1994;16:37-47.
40. [40] Yap L, Arrazola A, Soria F, Diez J. Is there increased cardiovascular risk in hypertensive patients with abnormal kinetics of red blood cell sodium-lithium countertransport? J Hypertens 1989;7:667-673.
41. + -countertransport in essential hypertension. J Hypertens 1988;6:931-937.
42. [42] De La Sierra A, Coca A, Pare JC, Sanchez M, Vails V, Urbano-Marquez A. Erythrocyte ion fluxes in essential hypertension patients with left ventricular hypertrophy. Circulation 1993;88:1628-1633.